These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31203806)

  • 1. Highly Potent and Selective Ectonucleoside Triphosphate Diphosphohydrolase (ENTPDase1, 2, 3 and 8) Inhibitors Having 2-substituted-7- trifluoromethyl-thiadiazolopyrimidones Scaffold.
    Afzal S; Zaib S; Jafari B; Langer P; Lecka J; Sévigny J; Iqbal J
    Med Chem; 2020; 16(5):689-702. PubMed ID: 31203806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterization and biological evaluation of thiadiazole amide derivatives as nucleoside triphosphate diphosphohydrolases (NTPDases) inhibitors.
    Abbas S; Afzal S; Nadeem H; Hussain D; Langer P; Sévigny J; Ashraf Z; Iqbal J
    Bioorg Chem; 2022 Jan; 118():105456. PubMed ID: 34800887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, In-vitro evaluation and molecular docking studies of oxoindolin phenylhydrazine carboxamides as potent and selective inhibitors of ectonucleoside triphosphate diphosphohydrolase (NTPDase).
    Afzal S; Al-Rashida M; Hameed A; Pelletier J; Sévigny J; Iqbal J
    Bioorg Chem; 2021 Jul; 112():104957. PubMed ID: 34020240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of new quinoline derivatives as promising inhibitors of NTPDases: Synthesis, SAR analysis and molecular docking studies.
    Hayat K; Afzal S; Saeed A; Murtaza A; Ur Rahman S; Khan KM; Saeed A; Zaib S; Lecka J; Sévigny J; Iqbal J; Hassan A
    Bioorg Chem; 2019 Jun; 87():218-226. PubMed ID: 30903944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent synthesis and elaboration of structure activity relationship for quinoline derivatives as highly selective NTPDase inhibitor.
    Murtaza A; Afzal S; Zaman G; Saeed A; Pelletier J; Sévigny J; Iqbal J; Hassan A
    Bioorg Chem; 2021 Oct; 115():105240. PubMed ID: 34416508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionalized Oxoindolin Hydrazine Carbothioamide Derivatives as Highly Potent Inhibitors of Nucleoside Triphosphate Diphosphohydrolases.
    Afzal S; Al-Rashida M; Hameed A; Pelletier J; Sévigny J; Iqbal J
    Front Pharmacol; 2020; 11():585876. PubMed ID: 33328992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schiff bases of tryptamine as potent inhibitors of nucleoside triphosphate diphosphohydrolases (NTPDases): Structure-activity relationship.
    Kanwal ; Mohammed Khan K; Salar U; Afzal S; Wadood A; Taha M; Perveen S; Khan H; Lecka J; Sévigny J; Iqbal J
    Bioorg Chem; 2019 Feb; 82():253-266. PubMed ID: 30391856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-Substituted 7-trifluoromethyl-thiadiazolopyrimidones as alkaline phosphatase inhibitors. Synthesis, structure activity relationship and molecular docking study.
    Jafari B; Ospanov M; Ejaz SA; Yelibayeva N; Khan SU; Amjad ST; Safarov S; Abilov ZA; Turmukhanova MZ; Kalugin SN; Ehlers P; Lecka J; Sévigny J; Iqbal J; Langer P
    Eur J Med Chem; 2018 Jan; 144():116-127. PubMed ID: 29268128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyoxometalates--a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors.
    Müller CE; Iqbal J; Baqi Y; Zimmermann H; Röllich A; Stephan H
    Bioorg Med Chem Lett; 2006 Dec; 16(23):5943-7. PubMed ID: 16997558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Anthraquinone Derivatives as Ectonucleoside Triphosphate Diphosphohydrolase (NTPDase) Inhibitors With Selectivity for NTPDase2 and NTPDase3.
    Baqi Y; Rashed M; Schäkel L; Malik EM; Pelletier J; Sévigny J; Fiene A; Müller CE
    Front Pharmacol; 2020; 11():1282. PubMed ID: 32973513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 8-BuS-ATP derivatives as specific NTPDase1 inhibitors.
    Lecka J; Gillerman I; Fausther M; Salem M; Munkonda MN; Brosseau JP; Cadot C; Martín-Satué M; d'Orléans-Juste P; Rousseau E; Poirier D; Künzli B; Fischer B; Sévigny J
    Br J Pharmacol; 2013 May; 169(1):179-96. PubMed ID: 23425137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trichomonas vaginalis NTPDase and ecto-5'-nucleotidase hydrolyze guanine nucleotides and increase extracellular guanosine levels under serum restriction.
    Menezes CB; Durgante J; de Oliveira RR; Dos Santos VH; Rodrigues LF; Garcia SC; Dos Santos O; Tasca T
    Mol Biochem Parasitol; 2016 May; 207(1):10-8. PubMed ID: 27150347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human and mouse plasma membrane bound NTPDases by P2 receptor antagonists.
    Munkonda MN; Kauffenstein G; Kukulski F; Lévesque SA; Legendre C; Pelletier J; Lavoie EG; Lecka J; Sévigny J
    Biochem Pharmacol; 2007 Nov; 74(10):1524-34. PubMed ID: 17727821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potentials of ecto-nucleoside triphosphate diphosphohydrolase, ecto-nucleotide pyrophosphatase/phosphodiesterase, ecto-5'-nucleotidase, and alkaline phosphatase inhibitors.
    al-Rashida M; Iqbal J
    Med Res Rev; 2014 Jul; 34(4):703-43. PubMed ID: 24115166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases.
    Lévesque SA; Lavoie EG; Lecka J; Bigonnesse F; Sévigny J
    Br J Pharmacol; 2007 Sep; 152(1):141-50. PubMed ID: 17603550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dynamic simulations reveal structural insights into substrate and inhibitor binding modes and functionality of Ecto-Nucleoside Triphosphate Diphosphohydrolases.
    Iqbal J; Shah SJA
    Sci Rep; 2018 Feb; 8(1):2581. PubMed ID: 29416085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of thienopyrimidine glycinates as selective inhibitors for h-NTPDases.
    Begum Z; Ullah S; Akram M; Uzair M; Ullah F; Ahsanullah ; Pelletier J; Sévigny J; Iqbal J; Hassan A
    Bioorg Chem; 2022 Dec; 129():106196. PubMed ID: 36279741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships of anthraquinone derivatives derived from bromaminic acid as inhibitors of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases).
    Baqi Y; Weyler S; Iqbal J; Zimmermann H; Müller CE
    Purinergic Signal; 2009 Mar; 5(1):91-106. PubMed ID: 18528783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of P2Y1 receptor-mediated signaling by the ectonucleoside triphosphate diphosphohydrolase isozymes NTPDase1 and NTPDase2.
    Alvarado-Castillo C; Harden TK; Boyer JL
    Mol Pharmacol; 2005 Jan; 67(1):114-22. PubMed ID: 15496502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation.
    Sévigny J; Sundberg C; Braun N; Guckelberger O; Csizmadia E; Qawi I; Imai M; Zimmermann H; Robson SC
    Blood; 2002 Apr; 99(8):2801-9. PubMed ID: 11929769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.